Whitepaper
Mass Personalization for Medical Device Therapy
Personalized medicine has proven to be a slow revolution due to the technical, regulatory, legal, ethical, and economic barriers we must first overcome. In this whitepaper, you'll discover the key drivers of mass personalization and how you can focus your efforts on accelerating this revolution.
What you will learn
- Why investing in personalized solutions will bring growth as demographics continue to change
- How you can succeed in making personalized treatment consistently more cost-effective than one-size-fits-all treatment
- Which new technologies are most likely to increase the impact personalized solutions can have on patient outcomes
Materialise医療機器ソフトウェアは、個々の現場の規制または医療慣行の対象となるため、すべての市場で販売されるとは限りません。 Mimicsまたは3-maticMedicalの規制登録を取得していない国では、調査版の利用が可能です。 お住まいの地域でのMaterialise医療機器ソフトウェアの入手可能性について質問がある場合は、Materialiseの担当者にお問い合わせください。
L-101617-02
以下で共有する：
